MAPK1 and melanoma: Other lower frequency mutations in melanoma include rare mutations in V-Akt murine thymoma viral oncogene homologs 1 and 3, (AKT1 and AKT3), and mutations in MAP2K1 and MAP2K2, which have demonstrated constitutive activation of the ERK pathway [39].